MAPT and Alzheimer disease: For example, it is well reported and extensively replicated that lower CSF Aβ-42 concentrations and higher CSF levels of total and phosphorylated tau (t-tau and p-tau, respectively) are typical findings among AD and mild cognitive impairment (MCI) patients [5,8].